UNSPSC 85373601: Diagnosis of progressive systemic sclerosis

This classification denotes the group of activities that yields a diagnosis of Progressive systemic sclerosis. Progressive systemic sclerosis is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as a four digit category under code M34. 0

UNSPSC 85373601 Diagnosis of progressive systemic sclerosis, a Commodity code, shows minimal alignment between its nominal scope and recent state and local procurement activity. The code's technical name describes a specific medical diagnostic category, but the opportunities posted under it span clinical imaging infrastructure (PACS systems), ultrasound equipment procurement, and phlebotomy services — none of which constitute diagnosis of a specific autoimmune disease. San Mateo Medical Center, a California county health system, is soliciting an RFP for enterprise-grade diagnostic imaging PACS implementation supporting radiology, cardiology, and dental imaging with EPIC integration, due August 7, 2026. Collier County, Florida, issued a notice of intent to single source ultrasound equipment (KOSMOS platform with TORSO-ONE USB probe) from EchoNous, Inc., with a contract term running March 26, 2026, to March 25, 2028. The Albuquerque Police Department posted an RFB for on-call blood draw services by certified phlebotomy technicians serving Bernalillo County, with responses due February 25, 2026. The issuing bodies are a mix of county health systems and municipal law enforcement, representing different procurement drivers and use cases.

Geographically, recent activity appears in California, Florida, and New Mexico, with no clear concentration in any single state or region. The code shows sparse recent activity overall, and the opportunities posted under it diverge significantly from its stated medical diagnostic purpose. Buyers should flag this mismatch with procurement offices when evaluating UNSPSC alignment — the code may be applied inconsistently across jurisdictions, or it may capture a broader family of clinical services than its name suggests. The opportunities present moderate complexity: the PACS solicitation requires vendor EPIC integration experience and references, the ultrasound procurement is single source (no competitive pathway), and the phlebotomy RFB emphasizes certification and 24/7 availability over technical sophistication. None of the three recent opportunities disclose budget ceilings, award values, or incumbent vendors, limiting preliminary cost forecasting.